Literature DB >> 25124994

Further evidence of the importance of RIT1 in Noonan syndrome.

Débora R Bertola1, Guilherme L Yamamoto, Tatiana F Almeida, Michelle Buscarilli, Alexander A L Jorge, Alexsandra C Malaquias, Chong A Kim, Vanessa N V Takahashi, Maria Rita Passos-Bueno, Alexandre C Pereira.   

Abstract

Noonan syndrome (NS) is an autosomal dominant disorder consisting of short stature, short and/or webbed neck, distinctive facial features, cardiac abnormalities, cryptorchidism, and coagulation defects. NS exhibits genetic heterogeneity, associated with mutated genes that participate in RAS-mitogen-activated protein kinase signal transduction. Recently, a new gene (RIT1) was discovered as the causative gene in 17 of 180 Japanese individuals who were negative for the previously known genes for NS and were studied using exome sequencing (four patients), followed by Sanger sequencing (13 patients). The present study used the same technique in 70 Brazilian patients with NS and identified six with RIT1 missense mutations. Thus, we confirm that RIT1 is responsible for approximately 10% of the patients negative for mutations in the previously known genes. The phenotype includes a high frequency of high birth weight, relative macrocephaly, left ventricular hypertrophy, and ectodermal findings, such as curly hair, hyperpigmentation, and wrinkled palms and soles. Short stature and pectus deformity were less frequent. The majority of patients with a RIT1 mutation did not show apparent intellectual disability. Because of the relatively high frequency of mutations in RIT1 among patients with NS and its occurrence in different populations, we suggest that it should be added to the list of genes included in panels for the molecular diagnosis of NS through targeted next-generation sequencing.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  RAS-MAPK signaling; RIT1; left ventricular hypertrophy; noonan syndrome; whole-exome sequencing

Mesh:

Substances:

Year:  2014        PMID: 25124994     DOI: 10.1002/ajmg.a.36722

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.

Authors:  Masako Yaoita; Tetsuya Niihori; Seiji Mizuno; Nobuhiko Okamoto; Shion Hayashi; Atsushi Watanabe; Masato Yokozawa; Hiroshi Suzumura; Akihiko Nakahara; Yusuke Nakano; Tatsunori Hokosaki; Ayumi Ohmori; Hirofumi Sawada; Ohsuke Migita; Aya Mima; Pablo Lapunzina; Fernando Santos-Simarro; Sixto García-Miñaúr; Tsutomu Ogata; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Shin-Ichi Inoue; Yoichi Matsubara; Shigeo Kure; Yoko Aoki
Journal:  Hum Genet       Date:  2015-12-29       Impact factor: 4.132

Review 2.  Array comparative genomic hybridization and genomic sequencing in the diagnostics of the causes of congenital anomalies.

Authors:  Krzysztof Szczałuba; Urszula Demkow
Journal:  J Appl Genet       Date:  2016-11-18       Impact factor: 3.240

3.  STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritability.

Authors:  Renata C Scalco; Vivian Hwa; Horacio M Domené; Héctor G Jasper; Alicia Belgorosky; Roxana Marino; Alberto M Pereira; Carlos A Tonelli; Jan M Wit; Ron G Rosenfeld; Alexander A L Jorge
Journal:  Eur J Endocrinol       Date:  2015-06-01       Impact factor: 6.664

4.  Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.

Authors:  Hélène Cavé; Aurélie Caye; Nehla Ghedira; Yline Capri; Nathalie Pouvreau; Natacha Fillot; Aurélien Trimouille; Cédric Vignal; Odile Fenneteau; Yves Alembik; Jean-Luc Alessandri; Patricia Blanchet; Odile Boute; Patrice Bouvagnet; Albert David; Anne Dieux Coeslier; Bérénice Doray; Olivier Dulac; Valérie Drouin-Garraud; Marion Gérard; Delphine Héron; Bertrand Isidor; Didier Lacombe; Stanislas Lyonnet; Laurence Perrin; Marlène Rio; Joëlle Roume; Sylvie Sauvion; Annick Toutain; Catherine Vincent-Delorme; Marjorie Willems; Clarisse Baumann; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2016-01-13       Impact factor: 4.246

Review 5.  A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.

Authors:  Michaela Nemcikova; Sarka Vejvalkova; Filip Fencl; Martina Sukova; Anna Krepelova
Journal:  Eur J Pediatr       Date:  2015-10-31       Impact factor: 3.183

6.  Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).

Authors:  Zhenhao Fang; Christopher B Marshall; Jiani C Yin; Mohammad T Mazhab-Jafari; Geneviève M C Gasmi-Seabrook; Matthew J Smith; Tadateru Nishikawa; Yang Xu; Benjamin G Neel; Mitsuhiko Ikura
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

7.  Prolapse of all cardiac valves in Noonan syndrome.

Authors:  Adikesava Naidu Otikunta; Y V Subbareddy; Praneeth Polamuri; Ashok Thakkar
Journal:  BMJ Case Rep       Date:  2015-02-25

8.  Expansion of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Genet Med Rep       Date:  2016-07-01

9.  The molecular functions of RIT1 and its contribution to human disease.

Authors:  Richard Van; Antonio Cuevas-Navarro; Pau Castel; Frank McCormick
Journal:  Biochem J       Date:  2020-08-14       Impact factor: 3.857

Review 10.  Recent advances in RASopathies.

Authors:  Yoko Aoki; Tetsuya Niihori; Shin-ichi Inoue; Yoichi Matsubara
Journal:  J Hum Genet       Date:  2015-10-08       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.